BRIEF published on 03/26/2025 at 09:11, 8 months 9 days ago 123fahrschule SE Reports Strong FY24 Results Sales Growth 123fahrschule SE EBITDA Positive FY24 Results Expansion Plans
PRESS RELEASE published on 03/26/2025 at 09:06, 8 months 9 days ago Original-Research: 123fahrschule SE (von NuWays AG): BUY 123fahrschule SE released positive FY24 results with increased sales and first-time positive EBITDA. Sales growth driven by Private Customers segment. Analyst recommendation updated to BUY with a target price of EUR 7.90 EBITDA Sales Growth 123fahrschule SE Analyst Recommendation FY24 Results
BRIEF published on 03/24/2025 at 09:06, 8 months 11 days ago 123fahrschule SE Anticipates Robust Growth with New Management 123fahrschule SE Growth Forecast Management Changes FY24 Results Simulator Demand
PRESS RELEASE published on 03/24/2025 at 09:01, 8 months 11 days ago Original-Research: 123fahrschule SE (von NuWays AG): Buy 123fahrschule SE appoints Dr. Andreas Günther to management board, anticipates strong FY24 results with increased sales, order intake, and profitability. Buy recommendation maintained with target price of EUR 7.20 Profitability Sales Growth 123fahrschule SE FY24 Results Dr. Andreas Günther
BRIEF published on 01/27/2025 at 08:05, 10 months 8 days ago 123fahrschule Reports Growth with Preliminary 2024 Results Financial Results Convertible Bond 2024 Growth 123fahrschule Simulator Division
PRESS RELEASE published on 01/27/2025 at 08:00, 10 months 8 days ago 123fahrschule with further growth - preliminary results for 2024 123fahrschule SE reports preliminary unaudited figures for 2024 financial year, achieving a sales record of EUR 22.8 million and expanding its management team Revenue Growth Management Team Preliminary Results 123fahrschule SE 2024 Financial Year
BRIEF published on 01/26/2025 at 20:30, 10 months 9 days ago 123fahrschule SE Announces Convertible Bond and Preliminary Financial Results Revenue Increase Profitability Preliminary Results Convertible Bond Subscription Rights
PRESS RELEASE published on 01/26/2025 at 20:25, 10 months 9 days ago EQS-Adhoc: 123fahrschule SE: Convertible Bond and preliminary figures 123fahrschule SE issues a convertible bond of up to EUR 3,391,485.90 with 7.5% interest and announces preliminary unaudited figures for 2024 with record revenue of EUR 22.8 million Preliminary Figures 123fahrschule SE Convertible Bond Revenue Record 2024 Financial Year
BRIEF published on 11/07/2024 at 13:36, 1 year ago 123fahrschule Advances Digitization Despite Political Uncertainties 123fahrschule SE Digitization Driving School Amendment Government Coalition License Cost Reduction
PRESS RELEASE published on 11/07/2024 at 13:31, 1 year ago 123fahrschule: Implementation and digitization process continues despite coalition rupture 123fahrschule SE continues implementation and digitization process of driving school training despite coalition rupture, aiming to reduce driving license costs by up to 1,000 euros annually 123fahrschule SE Driving School Training Digitization Process Coalition Rupture Driving License Costs
Published on 12/05/2025 at 02:35, 3 hours 39 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 14 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 9 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 14 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 43 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 23 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 48 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 58 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 3 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 14 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 29 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 29 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 13 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
